Albireo Pharma Inc (NASDAQ:ALBO)

32.78
Delayed Data
As of Apr 19
 -0.27 / -0.82%
Today’s Change
15.31
Today|||52-Week Range
39.87
+28.05%
Year-to-Date
No recent news for Albireo Pharma Inc.

Today’s Trading

Previous close33.05
Today’s open32.99
Day’s range32.38 - 33.48
Volume56,504
Average volume (3 months)64,287
Market cap$372.8M
Data as of 4:00pm ET, 04/19/2018

Growth & Valuation

Earnings growth (last year)+4.42%
Earnings growth (this year)+47.08%
Earnings growth (next 5 years)+19.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales1.93
Price/Book5.85

Competitors

 Today’s
change
Today’s
% change
NBRVNabriva Therapeutics...-0.13-2.51%
SBBPStrongbridge Biophar...-0.40-5.00%
NEOSNeos Therapeutics In...-0.30-3.53%
CMRXChimerix Inc-0.14-2.72%
Data as of 4:00pm ET, 04/19/2018

Financials

Next reporting dateMay 10, 2018
EPS forecast (this quarter)-$0.66
Annual revenue (last year)$11.4M
Annual profit (last year)-$16.4M
Net profit margin-143.88%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President &
Chief Executive Officer
Ronald H. W. Cooper
Chief Operating Officer
Jan Peter Mattsson
Corporate headquarters
Boston, Massachusetts

Forecasts